Systemically delivered checkpoint inhibitors have grown into the cornerstone of immuno-oncology. Now, a team at the Terasaki Institute for Biomedical Innovation in Los Angeles wants to improve the effects of the molecules through local delivery.
Hire with SEC
Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.
"*" indicates required fields